Biotech First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis August 24, 2026
Biotech Jury Finds in Cytek’s Favor on Three of Four Asserted Claims; Company to Challenge Remaining Finding August 22, 2026
Biotech Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 21, 2026
Biotech BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026 August 20, 2026
Biotech Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline August 20, 2026
Biotech IDEAYA Biosciences Announces Clinical Collaboration with Genentech in MTAP-Deleted KRAS G12D-Mutant Pancreatic Cancer August 19, 2026
Biotech Invitation to presentation of BioArctic’s second quarter report for April – June 2026 on August 26 at 9:30 a.m. CEST August 19, 2026
Biotech Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development August 19, 2026